Literature DB >> 17590434

Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression.

Joanne S Allard1, Yousef Tizabi, James P Shaffery, Kebreten Manaye.   

Abstract

Hypocretin (Hcrt, also known as orexin) is a hypothalamic neuropeptide linked to narcolepsy, a disorder diagnosed by the appearance of rapid eye-movement sleep (REMS)-state characteristics during waking. Major targets of Hcrt-containing fibers include the locus coeruleus and the raphe nucleus, areas with important roles in regulation of mood and sleep. A relationship between REMS and mood is suggested by studies demonstrating that REMS-deprivation (REMSD) ameliorates depressive symptoms in humans. Additional support is found in animal studies where antidepressants and REMSD have similar effects on monoamiergic systems thought to be involved in major depression. Recently, we have reported that Wistar-Kyoto (WKY) rats, an animal model of depression, have reduced number and size of hypothalamic cells expressing Hcrt-immunoractivity compared to the parent, Wistar (WIS) strain, suggesting the possibility that the depressive-like attributes of the WKY rat may be determined by this relative reduction in Hcrt cells [Allard, J.S., Tizabi, Y., Shaffery, J.P., Trouth, C.O., Manaye, K., 2004. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 38, 311-315]. In this study, we sought to test the hypothesis that REMSD would result in a greater increase in the number and/or size of hypothalamic, Hcrt-immunoreactive (Hcrt-ir) neurons in WKY, compared to WIS rats. The effect of REMSD, using the multiple-small-platforms-over-water (SPRD) method, on size and number of Hcrt-ir cells were compared within and across strains of rats that experienced multiple-large-platforms-over-water (LPC) as well as to those in a normal, home-cage-control (CC) setting. In accord with previous findings, the number of Hcrt-ir cells was larger in all three WIS groups compared to the respective WKY groups. REMSD produced a 20% increase (p<0.02) in the number of hypothalamic Hcrt-ir neurons in WKY rats compared to cage control WKY (WKY-CC) animals. However, an unexpected higher increase in number of Hcrt-ir cells was also observed in the WKY-LPC group compared to both WKY-CC (31%, p<0.001) and WKY-SPRD (20%, p<0.002) rats. A similar, smaller, but non-significant, pattern of change was noted in WIS-LPC group. Overall the data indicate a differential response to environmental manipulations where WKY rats appear to be more reactive than WIS rats. Moreover, the findings do not support direct antidepressant-like activity for REMSD on hypothalamic Hcrt neurons in WKY rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590434      PMCID: PMC2000483          DOI: 10.1016/j.npep.2007.04.006

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  84 in total

1.  Possible involvement of orexin in the stress reaction in rats.

Authors:  T Ida; K Nakahara; T Murakami; R Hanada; M Nakazato; N Murakami
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

Review 2.  Norepinephrine dysfunction in depression.

Authors:  A Anand; D S Charney
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

Review 3.  Stress, norepinephrine and depression.

Authors:  B E Leonard
Journal:  J Psychiatry Neurosci       Date:  2001       Impact factor: 6.186

4.  Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat.

Authors:  J P Gardner; C A Fornal; B L Jacobs
Journal:  Neuropsychopharmacology       Date:  1997-08       Impact factor: 7.853

Review 5.  Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus.

Authors:  J Harro; L Oreland
Journal:  Brain Res Brain Res Rev       Date:  2001-12

6.  Orexin-saporin lesions of the medial septum impair spatial memory.

Authors:  H R Smith; K C H Pang
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

7.  Fos expression in orexin neurons varies with behavioral state.

Authors:  I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

8.  Investigatory behavior of a novel conspecific by Wistar Kyoto, Wistar and Sprague-Dawley rats.

Authors:  W P Paré
Journal:  Brain Res Bull       Date:  2000-12       Impact factor: 4.077

Review 9.  Depression: a case of neuronal life and death?

Authors:  Ronald S Duman
Journal:  Biol Psychiatry       Date:  2004-08-01       Impact factor: 13.382

10.  Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior.

Authors:  Joshi John; Ming-Fung Wu; Lisa N Boehmer; Jerome M Siegel
Journal:  Neuron       Date:  2004-05-27       Impact factor: 17.173

View more
  12 in total

Review 1.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 2.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 3.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

4.  An augmented CO2 chemoreflex and overactive orexin system are linked with hypertension in young and adult spontaneously hypertensive rats.

Authors:  Aihua Li; Sarah H Roy; Eugene E Nattie
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

5.  Animal models of narcolepsy.

Authors:  Lichao Chen; Ritchie E Brown; James T McKenna; Robert W McCarley
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-08       Impact factor: 4.388

Review 6.  Cell type- and pathway-specific synaptic regulation of orexin neurocircuitry.

Authors:  Jing-Jing Liu; Vincent R Mirabella; Zhiping P Pang
Journal:  Brain Res       Date:  2018-10-05       Impact factor: 3.252

7.  CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis.

Authors:  Chul-Hyun Cho; Heon-Jeong Lee; Hyun Goo Woo; Ji-Hye Choi; Tiffany A Greenwood; John R Kelsoe
Journal:  Psychiatry Investig       Date:  2015-07-06       Impact factor: 2.505

8.  Global analysis of gene expression mediated by OX1 orexin receptor signaling in a hypothalamic cell line.

Authors:  Eric Koesema; Thomas Kodadek
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

Review 9.  OX1 and OX2 orexin/hypocretin receptor pharmacogenetics.

Authors:  Miles D Thompson; Henri Xhaard; Takeshi Sakurai; Innocenzo Rainero; Jyrki P Kukkonen
Journal:  Front Neurosci       Date:  2014-05-06       Impact factor: 4.677

10.  Sex-related effects of sleep deprivation on depressive- and anxiety-like behaviors in mice.

Authors:  Rocio E Gonzalez-Castañeda; Alma Y Galvez-Contreras; Carlos J Martínez-Quezada; Fernando Jauregui-Huerta; Joaquin Grcia-Estrada; Rodrigo Ramos-Zuñiga; Sonia Luquin; Oscar Gonzalez-Perez
Journal:  Exp Anim       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.